Experimental Drug Development Centre (EDDC) is Singapore’s national platform for drug discovery and development, hosted by the Agency for Science, Technology and Research (A*STAR). EDDC aims to develop therapeutics and diagnostics that save and improve the lives of patients in Singapore, Asia and around the world.

EDDC conducts clinical trials to evaluate the safety and efficacy of investigational product candidates. For more information regarding clinical trials of EDDC, please visit clinicaltrials.gov.

Our focus is to complete our ongoing clinical trials to demonstrate safety and efficacy of investigational product candidates in order to get regulatory approval.

Currently, EDDC does not offer an expanded access program. Access to our investigational products is limited to controlled clinical trials until such time as their safety, tolerability and effectiveness have been determined and confirmed by regulatory authorities. Access to our investigational products before adequate clinical trials have been conducted to establish clinical activity, along with safety and tolerability, may not be in the best interests of patients.

If you have questions about this expanded access policy, please contact us at info@eddc.sg.

EDDC may revise this policy at any time.